• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新西兰八旬老人(毛利族与非毛利族)的肌肉减少症与死亡率——LiLACS NZ队列研究

Sarcopenia and mortality in Indigenous and non-Indigenous New Zealand octogenarians-the LiLACS NZ cohort study.

作者信息

Moyes Simon A, Selak Vanessa, Plank Lindsay, Hikaka Joanna, Kerse Ngaire

机构信息

Faculty of Medical and Health Sciences, Department of General Practice & Primary Healthcare, School of Population Health, University of Auckland, PO Box 92019, Auckland, 1142, New Zealand.

Faculty of Medical and Health Sciences, Department of Epidemiology & Biostatistics, School of Population Health, University of Auckland, Auckland, New Zealand.

出版信息

Eur Geriatr Med. 2025 Jun 28. doi: 10.1007/s41999-025-01261-5.

DOI:10.1007/s41999-025-01261-5
PMID:40580279
Abstract

PURPOSE

As the population is ageing, age-related vulnerability to chronic infirmity has become of greater concern. Sarcopenia, low muscle strength and mass, is a major contributor to infirmity. Both sarcopenia and hand grip strength (HGS) are known to predict mortality in older people. This paper investigates the impact of ethnicity on this relationship in New Zealand octogenarians.

METHODS

This study used data from Life and Living in Advanced Age: A Cohort Study in New Zealand (LiLACS NZ), which recruited 421 Māori and 516 non-Māori with follow-up mortality data for over twelve years and had a median survival period of 6.02 years, 251 Māori and 374 non-Māori had sufficient data to be included in modelling. Survival analysis (Cox regression) assessed the association between HGS or probable sarcopenia (defined using HGS) and mortality, separately by ethnicity (Māori, non-Māori) and sex.

RESULTS

Hand grip strength was a predictor of mortality for non-Māori men (age-adjusted hazard ratio, aHR, per 1 kg increase in HGS, 0.93, 95% CI: 0.91-0.96) but not for women or Māori men. Probable sarcopenia was associated with an increased hazard of mortality among all groups, but the effect was statistically significant for non-Māori (men 1.97, 1.39-2.79; women 1.49, 1.08-2.06) and not Māori (men 1.55, 0.97-2.48; women 1.36, 0.79-2.34).

CONCLUSION

Hand grip strength, either as a continuous variable or to identify probable sarcopenia, remains an important indicator with high clinical utility in advanced age. However, its utility may need to be re-examined for Indigenous populations.

摘要

目的

随着人口老龄化,与年龄相关的慢性虚弱易感性已成为更受关注的问题。肌肉减少症,即肌肉力量和质量低下,是导致虚弱的主要因素。已知肌肉减少症和握力(HGS)均可预测老年人的死亡率。本文研究了种族对新西兰八旬老人这种关系的影响。

方法

本研究使用了来自《高龄生活与生存:新西兰队列研究》(LiLACS NZ)的数据,该研究招募了421名毛利人和516名非毛利人,并拥有超过十二年的随访死亡率数据,中位生存期为6.02年,251名毛利人和374名非毛利人有足够的数据纳入模型。生存分析(Cox回归)分别按种族(毛利人、非毛利人)和性别评估了握力或可能的肌肉减少症(使用握力定义)与死亡率之间的关联。

结果

握力是非毛利男性死亡率的预测指标(年龄调整风险比,aHR,握力每增加1千克,为0.93,95%置信区间:0.91 - 0.96),但对女性或毛利男性则不然。可能的肌肉减少症与所有组的死亡风险增加相关,但该效应在非毛利人中具有统计学意义(男性为1.97,1.39 - 2.79;女性为1.49,1.08 - 2.06),而在毛利人中则无统计学意义(男性为1.55,0.97 - 2.48;女性为1.36,0.79 - 2.34)。

结论

握力,无论是作为连续变量还是用于识别可能的肌肉减少症,在高龄人群中仍然是具有高临床效用的重要指标。然而,对于原住民群体,可能需要重新审视其效用。

相似文献

1
Sarcopenia and mortality in Indigenous and non-Indigenous New Zealand octogenarians-the LiLACS NZ cohort study.新西兰八旬老人(毛利族与非毛利族)的肌肉减少症与死亡率——LiLACS NZ队列研究
Eur Geriatr Med. 2025 Jun 28. doi: 10.1007/s41999-025-01261-5.
2
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
3
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
4
Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception.COVID-19 患者使用激素避孕的血栓栓塞风险。
Cochrane Database Syst Rev. 2023 Jan 9;1(1):CD014908. doi: 10.1002/14651858.CD014908.pub2.
5
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
6
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
9
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.
10
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.

本文引用的文献

1
Grip strength values and cut-off points based on over 200,000 adults of the German National Cohort - a comparison to the EWGSOP2 cut-off points.握力值和截断值基于超过 20 万德国国家队列成年人的数据 - 与 EWGSOP2 截断值的比较。
Age Ageing. 2023 Jan 8;52(1). doi: 10.1093/ageing/afac324.
2
Mortality outcomes and inequities experienced by rural Māori in Aotearoa New Zealand.新西兰奥特亚罗瓦农村毛利人的死亡率及不平等状况。
Lancet Reg Health West Pac. 2022 Aug 18;28:100570. doi: 10.1016/j.lanwpc.2022.100570. eCollection 2022 Nov.
3
Barriers and facilitators for Māori in accessing hospital services in Aotearoa New Zealand.
新西兰奥克兰的毛利人在获得医院服务方面的障碍和促进因素。
N Z Med J. 2021 Nov 26;134(1546):47-58.
4
Does the combination of resistance training and a nutritional intervention have a synergic effect on muscle mass, strength, and physical function in older adults? A systematic review and meta-analysis.抗阻训练与营养干预相结合对老年人的肌肉质量、力量和身体功能是否具有协同作用?一项系统评价与荟萃分析。
BMC Geriatr. 2021 Nov 12;21(1):639. doi: 10.1186/s12877-021-02491-5.
5
Terminal decline in objective and self-reported measures of motor function before death: 10 year follow-up of Whitehall II cohort study.死亡前客观和自我报告的运动功能指标的终末下降:Whitehall II 队列研究的 10 年随访。
BMJ. 2021 Aug 4;374:n1743. doi: 10.1136/bmj.n1743.
6
Four weeks of electromyostimulation improves muscle function and strength in sarcopenic patients: a three-arm parallel randomized trial.四周肌电刺激可改善肌少症患者的肌肉功能和力量:一项三臂平行随机试验。
J Cachexia Sarcopenia Muscle. 2021 Aug;12(4):843-854. doi: 10.1002/jcsm.12717. Epub 2021 Jun 9.
7
Motor function is the primary driver of the associations of sarcopenia and physical frailty with adverse health outcomes in community-dwelling older adults.肌肉减少症和身体虚弱与社区居住的老年人不良健康结果的关联主要受运动功能的驱动。
PLoS One. 2021 Feb 2;16(2):e0245680. doi: 10.1371/journal.pone.0245680. eCollection 2021.
8
Sarcopenia: prevalence, associated factors, and the risk of mortality and disability in Japanese older adults.肌少症:日本老年人的患病率、相关因素以及与死亡率和失能的关系。
J Cachexia Sarcopenia Muscle. 2021 Feb;12(1):30-38. doi: 10.1002/jcsm.12651. Epub 2020 Nov 25.
9
The clinical usefulness of muscle mass and strength measures in older people: a systematic review.老年人肌肉量和力量测量的临床实用性:一项系统评价。
Age Ageing. 2021 Jan 8;50(1):88-95. doi: 10.1093/ageing/afaa123.
10
Diagnostic cut-offs, prevalence, and biochemical predictors of sarcopenia in healthy Indian adults: The Sarcopenia-Chandigarh Urban Bone Epidemiological Study (Sarco-CUBES).健康印度成年人肌少症的诊断截止值、流行率和生化预测因素:肌少症-昌迪加尔城市骨骼流行病学研究(Sarco-CUBES)。
Eur Geriatr Med. 2020 Oct;11(5):725-736. doi: 10.1007/s41999-020-00332-z. Epub 2020 Jun 5.